TLRY - Tilray Brands, Inc.
NEXT EARNINGS:
Apr 14, 2026
EPS Est: $-0.14
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$8.00
DETAILS
HIGH:
$10.00
LOW:
$2.00
MEDIAN:
$10.00
CONSENSUS:
$8.00
UPSIDE:
1.01%
Market Cap:
801.89M
Volume:
2,217,535
Avg Volume:
9,779,833
52 Week Range:
3.5-23.2
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Beta:
2.11
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
CA
Employees:
2,650
IPO Date:
2018-07-19
EPS (TTM):
-33.80
P/E Ratio:
-0.13
Revenue (TTM):
1.13B
Total Assets:
2.90B
Total Debt:
451.09M
Cash & Equiv:
304.17M
Rev Growth (5Y):
22.7%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-123.1%
Debt/Equity:
0.22
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-01-08 | $-0.41 | $-0.14 | -192.9% | $303.9M | $201.3M | +51.0% |
| 2025-10-09 | $-0.00 | $-0.27 | +98.4% | $287.8M | $204.5M | +40.7% |
| 2025-07-28 | $0.02 | $-0.03 | +166.7% | $224.5M | $208.5M | +7.7% |
| 2025-04-08 | $-0.10 | $-0.04 | -150.0% | $185.8M | $249.7M | -25.6% |
| 2025-01-10 | $-0.10 | $-0.04 | -150.0% | $211.0M | $216.3M | -2.5% |
| 2024-10-10 | $-0.04 | $-0.04 | -11.1% | $200.0M | $218.7M | -8.5% |
| 2024-07-29 | $-0.04 | $-0.02 | -81.8% | $229.8M | $227.1M | +1.2% |
| 2024-04-09 | $-0.12 | $-0.05 | -140.0% | $188.3M | $225.2M | -16.4% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.13B | 1.07B | 844.72M | 792.12M | 619.67M | 405.33M | 179.30M | 28.63M | 15.17M | 6.47M | 443,703 | 0 |
| Net Income | (3.00B) | (333.80M) | (1.96B) | (601.05M) | (443.75M) | (102.54M) | (25.04M) | 22.84M | 3.12M | 305,123 | (5.27M) | (41,989) |
| EPS | -33.80 | -4.50 | -31.70 | -11.30 | -15.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.68 |
| Total Assets | 2.90B | 5.91B | 5.92B | 6.87B | 6.03B | 1.19B | 894.03M | 68.75M | 44.91M | 27.82M | 11.50M | N/A |
| Total Debt | 451.09M | 527.75M | 794.89M | 786.36M | 938.66M | 624.97M | 584.24M | 65.11M | 38.77M | 0 | 0 | N/A |
| Cash & Equivalents | 304.17M | 311.13M | 278.33M | 524.29M | 488.47M | 128.94M | 663.38M | 2.95M | 10.17M | 12.63M | 5.67M | N/A |
| Operating Cash Flow | (129.81M) | (42.11M) | 10.65M | (223.45M) | (53.99M) | (343.77M) | (62.97M) | (7.63M) | (4.48M) | (757,620) | (4.38M) | N/A |
| Free Cash Flow | (174.98M) | (81.96M) | (17.37M) | (266.39M) | (100.93M) | (442.00M) | (131.31M) | (21.50M) | (5.14M) | (4.19M) | (6.40M) | N/A |
| FCF per Share | -1.97 | -1.10 | -0.28 | -5.54 | -3.74 | -19.39 | -6.45 | -1.59 | -0.59 | -0.86 | -1.68 | N/A |
| Book Value | 2.07B | 4.69B | 4.47B | 5.55B | 4.46B | 380.01M | 269.10M | (6.17M) | 3.42M | 26.85M | 10.74M | N/A |
| Cash & ST Investments | 351.78M | 354.98M | 604.16M | 524.29M | 488.47M | 128.94M | 704.68M | 2.95M | 10.17M | 12.63M | 5.67M | N/A |
| ROC Equity | -1.45 | -0.07 | -0.44 | -0.11 | -0.10 | -0.27 | -0.09 | N/A | 0.91 | 0.01 | -0.49 | N/A |